Skip to content
About Us
Our Founders & Our Story
Leadership
Advisory Board
Our Team
Our Values
Investors
MicroOrganoSphere
TM
(MOS)
Technology
Precision
Oncology
Colorectal Cancer
Breast Cancer
Immuno-oncology
Drug
Development
Collaborators
News &
Publications
Careers
Contact Us
Menu
Durham biotech company raises $70 million
Post navigation
Previous Post
Cancer-treatment startup founded by Duke professors raises $70 million from investors
Next Post
Xilis draws in $70M in funding to bring down costs of drug development
vera
View posts by vera
Scroll to top
E-mail
Copy
E-mail
Copy
E-mail
